NEW YORK, Dec. 19, 2023 /PRNewswire/ — The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Icosavax Inc. (the “Company”) (NASDAQ: ICOSAVAX) stock prior to November 30th, 2023. You are hereby notified that Levi & Korsinsky, LLP has…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.